Welcome to Magnivel International

Hybrid Events: You can participate in person or virtually from your home or work
2nd International Conference on Dementia and Alzheimer's Disease

Dementia 2024

Oct 25-26, 2024 Location : Barcelona, Spain

2nd International Conference on Dementia and Alzheimer's Disease

Theme

Explicating Advancements to Battle the Silent Endemic of Dementia and Alzheimer
Dementia 2024

Welcome Message

Welcome to the 2nd International Conference on Dementia and Alzheimer's (Dementia 2024)!

 

It is with great pleasure and excitement that Magnivel International extends a heartfelt welcome to all esteemed participants, experts, and enthusiasts from around the world to join us for a groundbreaking journey at our upcoming event - 2nd International Conference on Dementia and Alzheimer's (Dementia 2024). Scheduled to take place on October 25-26, 2024 in the captivating city of Barcelona, Spain, this conference promises to be a convergence of minds dedicated to advancing the field of neurology and cognitive health.

 

As pioneers in Dementia and Alzheimer's research, we are committed to fostering collaborative discussions, sharing innovative insights, and exploring cutting-edge advancements that hold the potential to transform lives. Our conference serves as a dynamic platform where leading experts will come together to exchange ideas, present groundbreaking research, and forge meaningful connections aimed at advancing our collective understanding and treatment of these critical neurological conditions.

 

Nestled in the heart of Barcelona, a city renowned for its rich cultural heritage and captivating charm, our event offers more than just academic discourse. It provides a unique opportunity to immerse yourself in the vibrant tapestry of Spanish culture while engaging in enlightening discussions and forging connections with like-minded individuals from diverse backgrounds.

 

Join us as we embark on a transformative journey towards unraveling the mysteries of Dementia and Alzheimer's. Together, let us pave the way towards a brighter future for those affected by these conditions. Mark your calendars and prepare to be inspired, educated, and empowered as we come together in Barcelona for an unforgettable conference experience.

 

We invite you to submit your abstracts online or via email and be a part of this exceptional gathering of minds. Whether you are a researcher, clinician, caregiver, or advocate, your contributions are invaluable as we work towards improving the lives of millions affected by Dementia and Alzheimer's.

 

We eagerly anticipate welcoming you to Barcelona and embarking on this enlightening journey together. Let us join hands as we strive to make a difference in the field of neurology and cognitive health. See you in Barcelona!

About Conference

Dementia 2024 offers an invaluable platform for professionals and enthusiasts alike to delve into the complexities of neurology and cognitive health. Here are the benefits attendees can expect:

 

Cutting-Edge Insights: Dementia 2024 provides access to the latest research and advancements in the field. Attendees can stay abreast of cutting-edge insights into the mechanisms, diagnosis, and treatment of dementia and Alzheimer's disease.

 

Networking Opportunities: The conference brings together a diverse array of professionals, including doctors, scientists, neurologists, students, and sponsors, fostering a rich environment for networking. Participants can connect with leading experts, potential collaborators, and industry representatives, facilitating the exchange of ideas and fostering potential partnerships.

 

Professional Development: For young scientists, students, and professionals, Dementia 2024 offers a unique opportunity for professional development. Attendees can gain valuable knowledge, mentorship, and guidance from seasoned professionals, enhancing their skills and expanding their professional network.

 

Multidisciplinary Perspectives: With attendees from across the globe, Dementia 2024 provides a platform for multidisciplinary collaboration. Participants can gain insights from diverse perspectives, including clinical, scientific, and technological, enriching their understanding of dementia and Alzheimer's disease.

 

Innovative Solutions: The conference serves as a catalyst for innovation in the field of neurology. Through presentations, workshops, and discussions, attendees can explore innovative approaches to diagnosis, treatment, and care for individuals living with dementia and Alzheimer's disease.

 

Cultural Experience: Nestled in the captivating city of Barcelona, Dementia 2024 offers attendees a unique cultural experience. Beyond the conference sessions, participants can immerse themselves in the rich heritage, cuisine, and ambiance of Spain, adding an enriching dimension to their overall experience.

 

In summary, Dementia 2024 offers a comprehensive platform for advancing knowledge, fostering collaboration, and driving innovation in the field of neurology. Whether you are a seasoned professional or a budding enthusiast, this conference promises to be a transformative experience that you won't want to miss.

 

Join us in Barcelona as we work together to combat dementia and Alzheimer's disease and improve the lives of millions worldwide.

Market Analysis

Dementia and Alzheimer's diseases represent pressing global health challenges, with an increasingly aging population driving demand for effective treatments and interventions. The market for dementia and Alzheimer's therapeutics is projected to witness substantial growth in the coming years, fueled by rising prevalence rates and advancements in medical research.

 

Key market drivers include:

 

Growing Aging Population: The aging demographics worldwide contribute significantly to the increasing prevalence of dementia and Alzheimer's diseases, creating a substantial market for therapeutic interventions.

 

Rising Awareness and Diagnosis: Heightened awareness about dementia and Alzheimer's, coupled with improved diagnostic techniques, is leading to earlier detection and treatment initiation, expanding the addressable market.

 

Research and Development: Ongoing research efforts are focusing on understanding the underlying mechanisms of these diseases and developing innovative therapeutic approaches, fostering market expansion and competitive dynamics.

 

Healthcare Infrastructure Development: Improvement in healthcare infrastructure, particularly in emerging economies, is enhancing access to diagnosis and treatment options, further propelling market growth.

 

Key pharmaceutical companies operating in this sector include:

Biogen: Known for its pioneering work in Alzheimer's disease research, including the development of Aducanumab, an investigational treatment.

Eisai: Collaborating with Biogen on the development and commercialization of Alzheimer's therapies.

Pfizer: Engaged in research and development activities focused on Alzheimer's disease, with several compounds in clinical trials.

Johnson & Johnson: Conducting research on dementia and Alzheimer's, with a focus on novel therapeutic modalities.

Roche: Involved in the development of diagnostics and therapeutics for Alzheimer's disease, aiming to address unmet medical needs.

 

In conclusion, the dementia and Alzheimer's disease market presents significant growth opportunities driven by demographic trends, increased awareness, and ongoing research endeavors. Pharmaceutical companies play a pivotal role in advancing therapeutic options to address the evolving needs of patients and healthcare systems globally.

Scientific Sessions

  • Early Detection and Diagnosis of Alzheimer's Disease
  • Novel Therapeutic Approaches in Dementia Care
  • Alzheimer's Disease: Genetics, Risk Factors and Prevention
  • Neuroimaging Biomarkers in Dementia Research
  • Non-Pharmacological Interventions for Dementia 
  • Vascular Dementia: Pathogenesis and Treatment Strategies
  • Behavioral and Psychological Symptoms of Dementia
  • Caregiver Support and Interventions for Alzheimer's Disease
  • Frontotemporal Dementia: Clinical Updates
  • Technology and Innovation in Dementia Care
  • Mild Cognitive Impairment (MCI): Progression to Dementia
  • Nutrition and Lifestyle Interventions for Dementia Prevention
  • Lewy Body Dementia: Clinical Features and Diagnosis
  • Palliative Care and End-of-Life Considerations in Dementia
  • Biomarkers and Disease Progression in Alzheimer's Disease

Conference Highlights

Supporting Journals
Special Issues

All the accepted abstracts will be published in respective Magnivel International Journals. Abstracts will be provided with Digital Object Identifier (DOI) by img

Conference Schedule

Time Session
08:15 - 09:15 Registration and Opening Ceremony
09:15 - 10:15 Keynote Speech
10:15 - 10:45 Coffee Break and Group Photo
10:45 - 12:00 Panel Discussion - "Current Trends and Innovations"
12:00 - 01:00 Lunch Break and Networking
01:00 - 03:00 Panel Discussion - "Current Trends and Innovations"
03:00 - 03:30 Afternoon Coffee Break and and Networking
03:30 - 05:30 Panel Discussion - "Latest Advancements"
05:30 - 06:00 Video Presentations
Time Session
08:15 - 09:15 Registration and Networking
09:15 - 10:15 Keynote Speech
10:15 - 10:45 Morning Break and Group Photo
10:45 - 12:00 Panel Discussion - "Current Trends and Innovations"
12:00 - 01:00 Lunch Break and Networking
01:00 - 03:00 Panel Discussion - "Latest Advancements"
03:00 - 03:30 Afternoon Coffee Break and and Networking
03:30 - 05:30 Panel Discussion - "Latest Advancements"
05:30 - 06:00 Closing Ceremony

Get In Touch Make Inquiry

Please feel free to contact us for any information, all the queries will be answered by the conference secretariat within 24 hrs.

Venue - Hospitality & Attraction

Hotel: Hyatt Regency Barcelona Tower

Barcelona, Spain

  • Avinguda de la Granvia de l’Hospitalet, 144, 08907 Barcelona, Spain
  • https://www.hyatt.com/en-US/hotel/spain/hyatt-regency-barcelona- tower/bcnrb?src=corp_lclb_gmb_seo_bcnrb
Avinguda de la Granvia de l’Hospitalet, 144, 08907 Barcelona, Spain
Avinguda de la Granvia de l’Hospitalet, 144, 08907 Barcelona, Spain
Avinguda de la Granvia de l’Hospitalet, 144, 08907 Barcelona, Spain
Avinguda de la Granvia de l’Hospitalet, 144, 08907 Barcelona, Spain
Avinguda de la Granvia de l’Hospitalet, 144, 08907 Barcelona, Spain

Media Partners and collaborations

Magnivel International is an Open Access publisher and international scientific conferences and expo Organizer. We own and operate peer-reviewed clinical, medical, life sciences, engineering, and management journals and hosts scholarly conferences per year in the fields of clinical, medical, pharmaceutical, life sciences, business, engineering and technology.

Quick Links

Corporate Office